Oklahoma's cannabis industry faces regulatory fatigue as lawmakers urge a pause on new rules. How might this approach affect medical marijuana businesses and patients—and what lessons can the DMV take?

A documented increase in medical cannabis authorizers and broad clinician support could reshape patient access and operator strategy. Here’s how DMV readers can think about it.

Leafly’s October 2026 horoscopes spotlight a month shaped by planetary retrogrades with suggested strains. Here’s how DMV readers can use it wisely, from terpene tips to delivery compliance.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

MJBizDaily reports Florida’s $2B medical market hit by falling valuations and a failed adult-use push by 2026, raising real questions about operator exits and strategy pivots.

Through July 11, Ohio’s medical and adult-use cannabis market tallied $684.6 million and 150.3 million units sold, a pace MJBizDaily says could set a new annual high.

Seasonal harvest sends cannabis hiring to its yearly peak. Here’s how Croptober planning impacts supply, delivery operations, and compliance for DMV consumers and couriers.

Virginia’s cannabis regulator has posted draft adult-use rules, including license caps and fee proposals, with sales expected to begin July 1, 2027 if timelines hold.

A new Psychedelic Alpha podcast surveys D.C.’s psychedelic moment, the FDA’s evolving medical framework, and New Zealand’s MDMA prescribers—here’s why the DMV should care.

Four years after legalization, 24 planned adult-use cannabis stores in Rhode Island remain unopened amid licensing delays and regulatory bottlenecks, per MJBizDaily.

A Dec. 11 federal ban on intoxicating hemp products could hit retailers, delivery menus, and couriers nationwide. Here’s what DMV consumers and operators should prepare for.

Clinical trial momentum has regulators eyeing MDMA and psilocybin. Here’s how “abuse potential” factors into rescheduling talks—and what DMV readers should watch.

Psychedelic Alpha reports that two psychiatrists in New Zealand have been cleared to prescribe MDMA for PTSD. Here’s what happened and what DMV readers should know.

Psychedelic Alpha reports that Risk Evaluation and Mitigation Strategies are likely to shape how FDA-approved psychedelic therapies are delivered. Here’s what to watch.